摘要
目的探究舒利迭对支气管哮喘缓解期患者肺功能及气道高反应性的影响。方法选取2016年11月至2018年11月本院收治的140例支气管哮喘患者作为研究对象,根据治疗方式不同分为对照组与观察组,各70例。对照组给予常规治疗,观察组给予舒利迭治疗。比较两组患者的治疗效果、肺功能恢复情况及气道高反应性的变化。结果观察组治疗后疾病控制率高达100.00%,明显高于对照组的92.86%,比较差异有统计学意义(P<0.05)。观察组患者肺部功能改善情况明显优于对照组,比较差异有统计学意义(P<0.05);观察组患者气道高反应性激发试验阳性率为12.86%,显著低于对照组的34.29%,比较差异有统计学意义(P<0.05)。结论采用舒利迭治疗支气管哮喘缓解期患者疗效显著,能有效促进患者肺部功能的恢复,改善气道高反应性,值得临床应用推广。
Objective To explore the effect of Seretide on pulmonary function and airway hyperresponsiveness in patients with bronchial asthma in remission stage.Methods A total of 140 patients with bronchial asthma admitted to our hospital from November 2016 to November 2018 were selected as study subjects.The patients were divided into control group and observation group according to different treatment methods,with 70 cases in each group.The control group was given routine treatment,while the observation group was given Seretide treatment.The therapeutic effect,pulmonary function recovery and airway hyperresponsiveness were compared between the two groups.Results After treatment,the disease control rate of the observation group(100.00%)was higher than that of the control group(92.86%),the difference was statistically significant(P<0.05).The improvement of lung function in the observation group was also significantly better than that in the control group,the difference was statistically significant(P<0.05).The positive rate of airway hyperresponsiveness provocation test(12.86%)in the observation group was significantly lower than that in the control group(34.29%),the difference was statistically significant(P<0.05).Conclusion Seretide is effective in the treatment of bronchial asthma in remission stage.It can effectively promote the recovery of pulmonary function and improve airway hyperresponsiveness.It is worthy of clinical application and promotion.
作者
严正东
Yan Zhengdong(Department of Internal Medicine,Dalian Fourth People's Hospital,Dalian,Liaoning,116031,China)
出处
《当代医学》
2020年第17期80-82,共3页
Contemporary Medicine
关键词
舒利迭
支气管哮喘
肺功能缓解
气道高反应性
Seretide
Bronchial asthma
Pulmonary function remission
Airway hyperresponsiveness
